companydata.dkAMPLEXA GENETICS A/S: Financial statements 2015
CVR: 29428441
AMPLEXA GENETICS A/S (CVR 29428441) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 157,496 and a net result of DKK -3,373,569 compared with DKK -3,386,966 the year before. Equity amounted to DKK -19,582,406.
- Gross Profit
- 157,496 kr.
- Profit/Loss
- -3,373,569 kr.
- Equity
- -19,582,406 kr.
- Total Assets
- 2,308,712 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 157 t. | -3.4 mio. | -19.6 mio. | - |
| 2014 | - | -186 t. | -3.4 mio. | -16.2 mio. | - |
| 2013 | - | -786 t. | -5.9 mio. | -12.8 mio. | - |
| 2012 | - | -538 t. | -2.1 mio. | -7 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
As of November 2, 2015, Johan Jan Albinus Dahl has joined the board of directors of AMPLEXA GENETICS A/S.
As of September 30, 2015, Jørn Kildegaard Andersen has left the board of directors of AMPLEXA GENETICS A/S.
As of May 31, 2015, Leif Mosekilde has left the board of directors of AMPLEXA GENETICS A/S.
AMPLEXA GENETICS A/S has published its annual report for 2014. Gross profit came to DKK -185,712, and the net result was DKK -3,386,966.
About AMPLEXA GENETICS A/S
AMPLEXA GENETICS A/S is a Danish company of the type Aktieselskab based in Odense C, founded in 2006. The company is registered under the industry Anden teknisk rådgivning. The management consists of Hans Atli Eli Albinus Dahl. The company is owned by SCIENT. INVEST ApS, Conseco P/F and Sp/f D65 Holding. The company has 9 employees. In 2025, the company reported a gross profit of DKK 4,009,035 and a net result of DKK -1,583,233 compared with DKK -11,108,344 the year before. Equity amounted to DKK -10,313,267.